JAK2 inhibition sensitizes resistant EGFR-mutant lung adenocarcinoma to tyrosine kinase inhibitors.
Times cited: 30
The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis.
Neoplasia (United States).
Times cited: 191
Antitumorigenic potential of STAT3 alternative splicing modulation.
Proceedings of the National Academy of Sciences of the United States of America.
Times cited: 98